Subscribe To
Sana biotechnology highlights hypoimmune allogeneic car t cell programs and in vivo technology platform with six presentations at 2022 ash annual meeting
Transplanted hypoimmune (HIP)-modified allogeneic CD19-targeted CAR T cells control CD19+ tumor cells in fully immunocompetent allogeneic humanized mi...
December 11, 2022, 10:30 pm
Vincerx pharma presents preclinical data on vip943 in acute myeloid leukemia models at the 64th american society of hematology annual meeting 2022
Vincerx’s proprietary payload and linker technology and VIP943, a novel anti-CD123 antibody drug conj...
December 11, 2022, 3:05 pm
Harpoon therapeutics presents updated interim results at ash 2022 for novel t cell engager hpn217 in relapsed/refractory multiple myeloma
Clinically active across a wide dose range (2.15 to 24 mg) in a Phase 1 trial of heavily pretreated patients with relapsed/refractory multiple myeloma...
December 11, 2022, 3:00 pm
Bellicum announces presentation by unc at ash 2022 on potential abrogation of ic9 car t-cell toxicities with rimiducid
HOUSTON, Dec. 11, 2022 (GLOBE NEWSWIRE) — Bellicum Pharmaceuticals, Inc. (Nasdaq: BLCM), a leader in developing novel, controllable cellular immunot...
December 11, 2022, 3:00 pm
Fate therapeutics announces clinical safety and activity data of first-ever ipsc-derived car t-cell therapy at 2022 ash annual meeting
FT819 Off-the-Shelf CAR T-cell Product Candidate Derived from Clonal Engineered Master iPSC Line with novel ...
December 10, 2022, 3:00 pm
Replimune announces pricing of public offering
BOSTON, Dec. 08, 2022 (GLOBE NEWSWIRE) — Replimune Group, Inc. (Nasdaq: REPL), a clinical stage biotechnology company pioneering the development of ...
December 9, 2022, 2:04 am
Prometheus biosciences, inc. announces pricing of public upsized $500 million offering of common stock
SAN DIEGO, Dec. 08, 2022 (GLOBE NEWSWIRE) — Prometheus Biosciences, Inc. (Nasdaq: RXDX), a clinical-stage biotechnology company pioneering a precisi...
December 9, 2022, 12:39 am
Hcw biologics enters crada with national cancer institute
NCI Activated as Clinical Site for Phase 1b/2 Clinical Trial to Evaluate HCW9218 in Advanced Pancreatic Cancer MIRAMAR, Fla., Dec. 08, 2022 (GLOBE NEW...
December 8, 2022, 12:55 pm
Pharvaris shares soar on positive top-line phase 2 data from rapide-1 study as it releases 3q results
Pharvaris (NASDAQ:PHVS), a clinical-stage company developing novel, oral bradykinin-B2-receptor antagonists to treat and prevent hereditary angioedema...
December 8, 2022, 11:34 am
Context therapeutics reports encouraging preliminary phase 2 data for ona-xr in metastatic breast cancer
Context Therapeutics (NASDAQ:CNTX) has announced preliminary Phase 2 data from the ongoing SMILE trial of onapristone extended-release (ONA-XR), the c...
December 8, 2022, 8:38 am
U.s. approves conditions for airbus a321xlr to address fire risks
The U.S. Federal Aviation Administration said it has approved special conditions for the Airbus A321XLR after concerns were raised that a ...
December 8, 2022, 12:48 am
Hcw biologics is granted second fundamental patent: u.s. patent for multi-chain chimeric polypeptide created with tobi™ platform
Allowed Claims for novel Immunotherapeutic Compound Constructed with Tissue Factor as Platform for Targ...
December 7, 2022, 12:30 pm
Onconova therapeutics to present at the upcoming medinvest oncology investor conference
NEWTOWN, Pa., Dec. 07, 2022 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX), a clinical-stage biopharmaceutical company focused on disc...
December 7, 2022, 8:00 am
X4 pharmaceuticals announces proposed public offering
BOSTON, Dec. 06, 2022 (GLOBE NEWSWIRE) — X4 Pharmaceuticals, Inc. (Nasdaq: XFOR), a leader in the discovery and development of ...
December 6, 2022, 11:26 pm
Mindset pharma to participate in upcoming conferences in december 2022
TORONTO, Dec. 06, 2022 (GLOBE NEWSWIRE) -- Mindset Pharma Inc. (CSE: MSET) (FSE: 9DF) (OTCQB: MSSTF) (“Mindset” or the “Company”), a drug...
December 6, 2022, 7:00 am
Tiziana life sciences announces date of annual general meeting 2022
NEW YORK, Dec. 06, 2022 (GLOBE NEWSWIRE) -- Tiziana Life Sciences Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company en...
December 6, 2022, 7:00 am
Opthea to present at the floretina 2022 congress
MELBOURNE, Australia, Dec. 06, 2022 (GLOBE NEWSWIRE) -- Opthea Limited (ASX:OPT; NASDAQ:OPT), a clinical stage biopharmaceutical company developing ...
December 6, 2022, 6:00 am
Hillevax announces positive immunogenicity results for run-in cohort of nest-in1 phase 2b clinical trial of hil-214 norovirus vaccine candidate
BOSTON, Dec. 05, 2022 (GLOBE NEWSWIRE) — HilleVax, Inc. (Nasdaq: HLVX), a clinical-stage biopharmaceutical company focused on developing and commerc...
December 5, 2022, 11:30 am
Arvinas: promising science, poor data
ARVN has promising and novel science. This is the second time it produced underwhelming data....
December 5, 2022, 4:12 am
Bionomics announces accepted abstract and upcoming poster presentations at the american college of neuropsychopharmacology (acnp) 2022 annual meeting
ADELAIDE, Australia, Dec. 02, 2022 (GLOBE NEWSWIRE) — Bionomics Limited (Nasdaq: BNOX | ASX: BNO) (Bionomics or Company), a clinical-stage biopharma...
December 2, 2022, 11:00 am